Research

Research

  1. A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-blind, Three-Arm Study to Evaluate the Safety and Efficacy of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) Administration in Subjects with Severe Community-Acquired Pneumonia.
  2. A Randomized Placebo-Controlled Efficacy and Safety Study of 1 Year Treatment Duration With High- and Medium-Dose Inhaled Mometasone Furoate/Formoterol Combination Formulation Compared With Formoterol and High-Dose Inhaled Mometasone Furoate Monotherapy in Subjects With Moderate to Severe COPD.